The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

Keywords: transcatheter aortic valve replacement, quadricuspid aortic valve, aortic regurgitation, computational fluid dynamics, three-dimensional printing Citation: Zhang Y, Cai D, Wang W, Du H, Gu J ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Cusp overlap view improved valve positioning and significantly reduced pacemaker need, and hospital stay in TAVR with SEVs.

Visual auras, like those that occur in migraines, may be signs of small injuries to the brain’s visual cortex, according to a clinical trial at UC San Francisco that tracked the appearance of these ...

When we think of heart-related emergencies, we often picture heart attacks or strokes. But there’s another silent yet life-threatening condition that gets very little attention- aortic aneurysm.

Aortic valve stenosis is the most prevalent heart valve disease worldwide. Although interventional treatment options have rapidly improved in recent years, symptomatic aortic valve stenosis is still ...

The association of bicuspid aortic valve with aortic stenosis, aortic regurgitation, and infective endocarditis has been known for almost 150 years and with dissection of the aorta for 75 years.1These ...

Background Coarctation of the aorta (CoA) has good modern results, but large multicentre longitudinal data on outcomes, especially hospital resource utilisation through childhood and adolescence, are ...

The Queensland man's aorta, the biggest blood vessel in the body, had ballooned to about four times the usual size, leaving it in danger of rupturing.

BACKGROUND: Thoracic (TAA) and abdominal (AAA) aortic aneurysm are life-threatening diseases characterized by dilation, inflammation, and structural weakness; development of pharmacological therapies ...